Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot Study.

Syal, Gaurav; Mishkin, Daniel S; Banty, Andrea; Lee, Susie; Fontelera, Norma; Hampton, Melissa; Ziring, David; Fleshner, Phillip R; Melmed, Gil Y

Syal, Gaurav; Mishkin, Daniel S; Banty, Andrea; Lee, Susie; Fontelera, Norma; Hampton, Melissa; Ziring, David; Fleshner, Phillip R; Melmed, Gil Y.

Afiliación

Syal G; Division of Gastroenterology and Hepatology, University of California San Diego, San Diego, CA, USA.
Mishkin DS; Atrius Health, Boston, MA, USA.
Banty A; Karsh Division of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Lee S; Karsh Division of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Fontelera N; Karsh Division of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Hampton M; Karsh Division of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Ziring D; Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Fleshner PR; Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Melmed GY; Karsh Division of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Inflamm Bowel Dis ; 2023 Oct 28.

Article en En | MEDLINE | ID: mdl-37898112

Palabras clave

calprotectin; chronic pouchitis; modified pouch disease activity index; tofacitinib

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Inflamm Bowel Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google